EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Effect of Dexmedetomidine on Postpartum Depression in Women With Prenatal Depression

Yingyong Zhou, Zhihong Bai, Wenchao Zhang, Shouyu Xu, Yunfei Feng, Qiuwen Li, Lishan Li, Anqi Ping, Liang Chen, Saiying Wang, Kaiming Duan

JAMA Network Open · 2024

DOI: 10.1001/jamanetworkopen.2023.53252 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift JAMA Network Open, 2024. Verfasst von Yingyong Zhou und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, The Third Xiangya Hospital of Central South University, Changsha, China. Hauptthemen laut MEDLINE: Depression, Postpartum, Dexmedetomidine. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Postpartum depression (PPD) is emerging as a major public health problem worldwide. Although the particular period and context in which PPD occurs provides an opportunity for preventive interventions, there is still a lack of pharmacologic prevention strategies for PPD.

Objective

To assess the efficacy and safety of dexmedetomidine for prevention of PPD among women with prenatal depression undergoing cesarean delivery. Design, Setting, and Participants This randomized clinical trial enrolled 338 women who screened positive for prenatal depression at 2 hospitals in Hunan, China from March 28, 2022, to April 16, 2023. Women with an Edinburgh Postnatal Depression Scale score of more than 9 who were 18 years of age or older and were scheduled for elective cesarean delivery were eligible.

Interventions

Eligible participants were randomly assigned in a 1:1 ratio to either the dexmedetomidine group or the control group via centrally computer-generated group randomization. Dexmedetomidine, 0.5 μg/kg and 0.9% saline were intravenously infused for 10 minutes after delivery in the dexmedetomidine and control groups, respectively. After infusion, sufentanil or dexmedetomidine plus sufentanil was administered via patient-controlled intravenous analgesia for 48 hours in the control group and dexmedetomidine group, respectively. Main Outcomes and Measures The primary outcome was positive PPD screening results at 7 and 42 days post partum, defined as a postpartum Edinburgh Postnatal Depression Scale score of more than 9. Analysis was on an intention-to-treat basis.

Results

All 338 participants were female, with a mean (SD) age of 31.5 (4.1) years. Positive PPD screening incidence at 7 and 42 days post partum in the dexmedetomidine group vs the control group was significantly decreased (day 7, 21 of 167 [12.6%] vs 53 of 165 [32.1%]; risk ratio, 0.39 [95% CI, 0.25-0.62]; P < .001; day 42, 19 of 167 [11.4%] vs 50 of 165 [30.3%]; risk ratio, 0.38 [95% CI, 0.23-0.61]; P < .001). The dexmedetomidine group showed no significant difference in adverse events vs the control group (46 of 169 [27.2%] vs 33 of 169 [19.5%]; P = .10), but the incidence of hypotension increased (31 of 169 [18.3%] vs 16 of 169 [9.5%]; risk ratio, 2.15 [95% CI, 1.13-4.10]; P = .02). Conclusions and Relevance Dexmedetomidine administration in the early postpartum period significantly reduced the incidence of a positive PPD screening and maintained a favorable safety profile. Trial Registration Chinese Clinical Trial Registry Identifier: ChiCTR2200057213

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Depression, PostpartumDexmedetomidineAdultFemaleHumansPregnancyAdministration, IntravenousSufentanil

Substanzen

DexmedetomidineSufentanil

Autor:innen und Institutionen

  • Department of Anesthesiology, The Third Xiangya Hospital of Central South University, Changsha, China.
  • Department of Anesthesiology, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China.
  • Department of Anesthesiology, The Maternal and Child Health Hospital of the Hu Nan Province, Changsha, China.

Zitieren

APA

Zhou, Y., Bai, Z., Zhang, W., Xu, S., Feng, Y., Li, Q., Li, L., Ping, A., Chen, L., Wang, S., & Duan, K. (2024). Effect of Dexmedetomidine on Postpartum Depression in Women With Prenatal Depression. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2023.53252

Vancouver

Zhou Y, Bai Z, Zhang W, Xu S, Feng Y, Li Q, et al. Effect of Dexmedetomidine on Postpartum Depression in Women With Prenatal Depression. JAMA Network Open. 2024. doi:10.1001/jamanetworkopen.2023.53252

BibTeX
@article{Zhou2024,
  author = {Zhou, Yingyong and Bai, Zhihong and Zhang, Wenchao and Xu, Shouyu and Feng, Yunfei and Li, Qiuwen and Li, Lishan and Ping, Anqi and Chen, Liang and Wang, Saiying and Duan, Kaiming},
  title = {Effect of Dexmedetomidine on Postpartum Depression in Women With Prenatal Depression},
  journal = {JAMA Network Open},
  year = {2024},
  doi = {10.1001/jamanetworkopen.2023.53252}
}
Kostenlos starten →